Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.11 EUR | +1.07% | +0.68% | -20.13% |
Nov. 28 | EUROFINS SCIENTIFIC : NAV cut by -6.0% | |
Nov. 11 | CAC40: crosses 7400 pts on Armistice Day | CF |
Capitalization | 8.92B 9.43B 8.28B 7.4B 13.34B 798B 14.75B 103B 38.04B 328B 35.39B 34.62B 1,414B | P/E ratio 2024 * |
21.1x | P/E ratio 2025 * | 17.5x |
---|---|---|---|---|---|
Enterprise value | 11.91B 12.59B 11.06B 9.88B 17.82B 1,066B 19.7B 138B 50.79B 437B 47.25B 46.23B 1,889B | EV / Sales 2024 * |
1.71x | EV / Sales 2025 * | 1.58x |
Free-Float |
66.44% | Yield 2024 * |
1.28% | Yield 2025 * | 1.53% |
Last Transcript: Eurofins Scientific SE
1 day | +1.07% | ||
1 week | +0.32% | ||
Current month | +0.68% | ||
1 month | +2.84% | ||
3 months | -10.44% | ||
6 months | -15.36% | ||
Current year | -20.13% |
Director | Title | Age | Since |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 1986-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 2014-12-31 |
Christian Wurst
COO | Chief Operating Officer | - | 2019-09-30 |
Manager | Title | Age | Since |
---|---|---|---|
Gilles Martin
CHM | Chairman | 61 | 1986-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 58 | 2014-12-31 |
Valérie Hanote
BRD | Director/Board Member | 58 | 1990-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 20 M€ | +16.75% | - | |
0.40% | 5 M€ | +4.56% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+1.07% | +0.32% | -13.46% | -55.10% | 9.33B | ||
-0.09% | -1.76% | +26.63% | +39.00% | 81.07B | ||
-2.76% | -7.79% | -22.15% | -39.15% | 71.55B | ||
+1.26% | +7.46% | +0.77% | +72.16% | 26.88B | ||
+1.56% | +1.90% | +194.53% | +98.30% | 22.31B | ||
-0.88% | +1.75% | +17.24% | +0.66% | 20.22B | ||
-0.99% | -3.96% | +7.17% | -19.89% | 19.65B | ||
-0.74% | -3.66% | +16.65% | +0.18% | 17.69B | ||
0.00% | +10.20% | +20.70% | -15.23% | 14.18B | ||
-0.69% | -3.25% | +53.19% | +62.13% | 13.23B | ||
Average | +0.08% | +0.53% | +30.13% | +14.31% | 29.61B | |
Weighted average by Cap. | +0.11% | -0.81% | +22.26% | +14.22% |
2024 * | 2025 * | |
---|---|---|
Net sales | 6.95B 7.34B 6.45B 5.77B 10.4B 622B 11.49B 80.33B 29.64B 255B 27.57B 26.97B 1,102B | 7.5B 7.93B 6.96B 6.22B 11.22B 671B 12.4B 86.67B 31.98B 275B 29.75B 29.11B 1,189B |
Net income | 413M 436M 383M 342M 617M 36.93B 682M 4.77B 1.76B 15.15B 1.64B 1.6B 65.44B | 506M 535M 470M 420M 757M 45.28B 837M 5.85B 2.16B 18.58B 2.01B 1.96B 80.24B |
Net Debt | 2.99B 3.16B 2.78B 2.48B 4.47B 268B 4.95B 34.57B 12.76B 110B 11.87B 11.61B 474B | 2.92B 3.08B 2.71B 2.42B 4.37B 261B 4.83B 33.74B 12.45B 107B 11.58B 11.33B 463B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-06 | 47.11 € | +1.07% | 415,346 |
24-12-05 | 46.61 € | 0.00% | 371,489 |
24-12-04 | 46.61 € | +1.26% | 389,257 |
24-12-03 | 46.03 € | -1.41% | 334,884 |
24-12-02 | 46.69 € | -0.21% | 302,793 |
Real-time Euronext Paris, December 06, 2024 at 11:35 am EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERF Stock